Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This is a placebo and active-controlled phase 2b dose-finding study to evaluate efficacy and safety of QGE031 monthly subcutaneous injections as add-on therapy in patients with Chronic Spontaneous Urticaria.
Epistemonikos ID: 80a16cad1e18264521f83e02a09b8a01e94ad08c
First added on: May 12, 2024